| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 4.933 | 27.945 | 9.824 | 13.221 | 115.164 |
| Total Income - EUR | - | - | - | - | - | 4.933 | 27.945 | 9.824 | 13.221 | 115.275 |
| Total Expenses - EUR | - | - | - | - | - | 563 | 3.572 | 6.917 | 25.636 | 85.162 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 4.370 | 24.372 | 2.907 | -12.415 | 30.114 |
| Net Profit/Loss - EUR | - | - | - | - | - | 4.222 | 23.534 | 2.613 | -12.585 | 25.117 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 2 |
Check the financial reports for the company - Neogyn Life S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 30.074 | 69.437 | 255.804 |
| Current Assets | - | - | - | - | - | 4.335 | 27.911 | 1.424 | 14.114 | 27.078 |
| Inventories | - | - | - | - | - | 0 | 0 | 439 | 13.108 | 3.925 |
| Receivables | - | - | - | - | - | 0 | 0 | 0 | 0 | 831 |
| Cash | - | - | - | - | - | 4.335 | 27.911 | 985 | 1.006 | 22.321 |
| Shareholders Funds | - | - | - | - | - | 4.264 | 27.703 | 30.402 | 17.725 | 42.743 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 71 | 208 | 1.096 | 65.826 | 240.139 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neogyn Life S.r.l.